BeiGene Reports First Quarter 2024 Financial Results and Business Updates
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced results from the first quarter 2024...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced results from the first quarter 2024...
Dr. Srikanth Dikkala, MBBS, DNB (Rad Onc), DNB (Medical Oncology), Consultant Medical Oncology, HCG Cancer Centre, Vizag Visakhapatnam, 14, December...